Practice Management Alert

Reader Question:

Share Your Thoughts on Noridian's IGIV LCD

Question: I heard there was a new IGIV LCD for Noridian, but I can't find it. Where should I look?Alaska SubscriberAnswer: In August, Noridian announced a draft (not final) Part B local coverage determination (LCD) for IGIV (Immune Globulin Intravenous), also called IVIG. The comment period for the draft LCD ends Nov. 12, 2012.To access the draft LCD:Start at www.noridianmedicare.com/partb/coverage/draft.html Select your stateChoose the draft LCD based on the title: DL32846, Immune Globulin Intravenous (IGIV).The draft addresses indications for IGIV use for:Pregnant women with idiopathic thrombocytopenic purpura (ITP)Certain neurologic disordersSymptomatic human immunodeficiency virus (HIV)Chronic lymphocytic leukemia with hypogammaglobulinemiaBone marrow/stem cell transplantKawasaki diseaseKidney or stem cell transplant rejection.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Practice Management Alert

View All